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BRIEF DEFINITIVE REPORT
           Cyclophilins constitute a family of phyloge-
netically conserved proteins found in prokar-
yotes as well as in humans. Cyclophilins have 
peptidyl-prolyl isomerase activity in vitro (  1  ), 
indicating that they infl  uence the conforma-
tion of proteins in cells, but their functions 
are largely unknown (  2  ). The founding mem-
ber of the cyclophilin family (15 members 
in humans), cyclophilin A (CypA), is an abun-
dant, ubiquitously expressed protein originally 
discovered as an intracellular ligand of the 
immunosuppressive drug cyclosporin A (CsA) ( 3  ). 
CypA      /      embryonic stem cells grow nor-
mally and diff  erentiate into hematopoietic pre-
cursor cells in vitro, indicating that CypA is 
not essential for mammalian cell viability (  4  ). 
CypA      /      mice appear phenotypically normal, 
but with reduced fertility (unpublished data), 
and are resistant to immunosuppression by 
CsA (  5  ). Immunosuppression is mediated by 
the CypA  –  CsA complex that inhibits calci-
neurin, a phosphatase crucial for T cell activa-
tion (  6  ). CypA expression is particularly high 
in the brain, in neurons, where it is expressed 
mainly in the cytoplasm but also in the nucleus 
(  7  ). Pioneeering work by Montague et al. re-
vealed that CypA possesses a latent, apoptosis-
related DNase activity (  8, 9  ). CypA has been 
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  Upon cerebral hypoxia-ischemia (HI), apoptosis-inducing factor (AIF) can move from mito-
chondria to nuclei, participate in chromatinolysis, and contribute to the execution of cell 
death. Previous work (Cande, C., N. Vahsen, I. Kouranti, E. Schmitt, E. Daugas, C. Spahr, 
J. Luban, R.T. Kroemer, F. Giordanetto, C. Garrido, et al. 2004.   Oncogene  . 23:1514–1521) 
performed in vitro suggests that AIF must interact with cyclophilin A (CypA) to form a 
proapoptotic DNA degradation complex. We addressed the question as to whether elimina-
tion of CypA may afford neuroprotection in vivo. 9-d-old wild-type (WT), CypA  /     , or 
CypA      /      mice were subjected to unilateral cerebral HI. The infarct volume after HI was 
reduced by 47% (P  0.0089) in CypA      /      mice compared with their WT littermates. 
Importantly, CypA      /      neurons failed to manifest the HI-induced nuclear translocation of AIF 
that was observed in WT neurons. Conversely, CypA accumulated within the nuclei of 
damaged neurons after HI, and this nuclear translocation of CypA was suppressed in 
AIF-defi  cient harlequin mice. Immunoprecipitation of AIF revealed coprecipitation of CypA, 
but only in injured, ischemic tissue. Surface plasmon resonance revealed direct molecular 
interactions between recombinant AIF and CypA. These data indicate that the lethal trans-
location of AIF to the nucleus requires interaction with CypA, suggesting a model in which 
two proteins that normally reside in separate cytoplasmic compartments acquire novel 
properties when moving together to the nucleus. 1742 NUCLEAR CO-TRANSLOCATION OF C  YP  A AND AIF | Zhu et al.
considering that the infarct cores are beyond rescue and that 
neuroprotective strategies can salvage only penumbral areas. 
The degree of protection is in the same range as that observed 
for mice with relative AIF defi  ciency, the so-called Hq 
mice (  22  ). A functional connection between AIF and CypA 
was recently found in vitro, demonstrating that AIF and 
CypA bind to each other upon induction of apoptosis in 
Jurkat cells and that the AIF  –  CypA complex, but neither of 
the individual constituents alone, could produce nonspecifi  c, 
large-scale DNA degradation (  14  ). 
  We next examined the mechanisms underlying the neuro-
protective eff  ect of CypA defi  ciency. No CypA protein 
was detected in CypA      /      mice, and the level of CypA pro-
tein was reduced     50% in CypA  /      compared with WT 
mice, as judged by immunoblotting (  Fig. 2 A  ). CypA      /      
mice were not phenotypically diff  erent from WT mice, 
and the brain morphology was not diff  erent between the 
two genotypes (unpublished data). The expression of nei-
ther the mitochondrial proapoptotic proteins AIF, Cyt c, and 
Smac, nor the mitochondrial oxidative stress  –  related proteins 
SOD2 and Trx2, were changed in CypA      /      nonischemic 
mice compared with CypA  /      or WT mice (  Fig. 2 A  ). 24 h 
after HI, the mitochondrial proteins AIF, cyt c, Smac, and 
SOD2 were reduced in the mitochondrial fraction of the ip-
silateral cortex compared with the contralateral side, but the 
decrease was the same in WT and CypA      /      mice (  Fig. 2 B  ). 
Thus, CypA defi  ciency does not inhibit the mitochondrial 
release of cell-death eff  ectors. The nonmitochondrial oxi-
dative stress  –  related proteins catalase and SOD1 were not 
changed at 24 h after HI (  Fig. 2 C  ). Hsp70, a chaperone 
known to counteract the proapoptotic eff  ects of AIF, was not 
diff  erent between WT and CypA      /      mice (  Fig. 2 C  ). The fo-
drin breakdown products generated by calpain (145/150 kD) 
and caspase-3 activation (120 kD) were not diff  erent be-
tween WT and CypA      /      mice, nor was the calpain-induced 
degradation of Na    /Ca  2   exchanger 1 (NCX1;   Fig. 2 C  ) (  23  ). 
Accordingly, the capacity to cleave caspase-3 (  Fig. 2 D  ) and 
caspase-9 (not depicted) peptide substrates was not diff  er-
ent in WT compared with CypA      /      mice in homogenates 
of normal control or postischemic cortical tissue 24 h after 
HI. Thus, CypA defi  ciency had no eff  ect on the HI-induced 
activation of proteases, including calpains and caspases. The 
levels of AIF, HSP70, or oxidative stress  –  related proteins 
were not diff  erent between WT and CypA      /      mice and, 
hence, cannot explain the AIF-related, protective eff  ects ob-
served in CypA      /      mice. The AIF defi  ciency in Hq mice 
reduces the antioxidant defense of neurons, thereby enhanc-
ing their susceptibility to oxidative stress (  22, 24  ), but we 
could not fi  nd any indications of altered levels of antioxida-
tive stress  –  related proteins in CypA      /      mice. Interestingly, 
caspase-3  –   and caspase-9  –  like activities increased after HI to 
a similar level in WT and CypA      /      mice despite the fact that 
WT mice developed brain infarcts that were almost twice 
as large as those from CypA      /      mice. This is in accordance 
with our previous fi  nding that the neuroprotection aff  orded 
by the Hq mutation does not correlate with reduced caspase 
demonstrated to participate in excitotoxin-induced apopto-
sis (  10  ) and to   interact with a limited number of proteins, 
including dynein (  11  ), the antioxidant protein Aop1 (  12  ), the 
nuclear pore protein Nup358 (  13  ), and apoptosis-inducing 
factor (AIF) (  14  ). 
  CypA cooperates with AIF during apoptosis-associated 
chromatinolysis in vitro (  14  ). Jurkat cells lacking CypA ex-
pression are relatively resistant to AIF-induced cell death (  14  ). 
Similarly, disruption of the CypA homologue   CPR1   in 
yeast cells abrogated cell death induced by overexpression of 
AIF (  15  ). In   Caenorhabditis elegans  , AIF (WAH-1) was found 
to interact with a cyclophilin within the molecular complex 
that mediates DNA degradation in apoptosis (  16  ). In vitro, 
recombinant AIF and recombinant CypA together have a 
higher DNase activity than each of the proteins alone (  14  ). 
Mutant CypA that lacks peptidyl-prolyl isomerase activ-
ity still co  operates with AIF to mediate chromatinolysis, 
and the proapoptotic cooperation of CypA and AIF was not 
inhibited by CsA (  14  ), indicating that CsA is not a pharma-
cological tool to investigate the contribution of CypA and 
AIF to cell death. 
  We and others have demonstrated that AIF plays an im-
portant role in neuronal death after focal ischemia in the adult 
rodent brain (  17  –  20  ) and after neonatal hypoxia-ischemia 
(HI) (  21, 22  ). AIF translocates from mitochondria to the 
nuclei of dying neurons, and inhibition of this translocation 
(  18, 19  ) or reduction of AIF expression through the harle-
quin (Hq) mutation is neuroprotective (  17, 22  ). Thus, AIF 
contributes to the pathogenesis of adult stroke and perinatal 
asphyxia. The aim of this study was to explore the possible 
involvement of CypA in brain injury induced by neonatal 
HI. We demonstrate that CypA and AIF functionally and 
physically interact in vivo in neonatal HI and in vitro using 
surface plasmon resonance, and that the CypA knockout 
confers resistance against HI-induced neuronal loss. 
    RESULTS AND DISCUSSION   
  Impact of CypA defi  ciency on brain injury after HI 
  Brain injury was signifi  cantly reduced at 72 h after HI in all 
four examined brain regions of CypA      /      mice compared 
with WT and CypA  /      littermates, as evaluated by neuro-
pathological scores, but there were no signifi  cant diff  erences 
between the WT and CypA  /      groups (  Fig. 1, A and B  ).   
The total infarct volume was reduced by 46.7% (P  0.0089) 
in CypA      /      mice (12.72      3.19 mm  3  ;   n    19) compared 
with WT mice (23.87      3.22 mm  3  ;   n    25; Fig. 1 C).   The 
infarct volume was reduced by 13.6% in CypA  /      mice 
(20.62      2.25 mm  3  ;   n    27), which was not signifi  cantly dif-
ferent from WT mice (  Fig. 1 C  ). The total tissue loss was 
  reduced by 33.8% in CypA      /      mice (28.37      3.87 mm  3  ) 
compared with WT mice (42.86      3.50 mm  3  ) and by 29.9% 
compared with CypA  /      mice (40.48      2.21 mm  3  ; Fig. 1 D). 
This is the fi  rst in vivo study showing that CypA defi  ciency is 
neuroprotective. The degree of protection against HI-induced 
infarction is impressive (almost 50%), which is probably close 
to the maximum that can be attained in this animal model, JEM VOL. 204, August 6, 2007  1743
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mice carrying the Hq mutation, CypA staining in the nucleus 
was reduced (  Fig. 3 C  ). These data suggest that CypA is 
required for the optimal nuclear translocation of AIF in 
damaged neurons and, vice versa, that AIF is needed for the 
nuclear translocation of CypA after HI. Accordingly, CypA 
coimmunoprecipitated with AIF in the ipsilateral, ischemic 
hemisphere but not in normal control tissue (  Fig. 4 A  ).   This 
suggested a direct physical interaction between AIF and 
CypA, and this was confi  rmed using surface plasmon reso-
nance (Biacore). Recombinant AIF was captured by an anti-
body immobilized to the sensor surface, and recombinant 
CypA bound to and was released from the captured AIF with 
an apparent dissociation constant (K  d  ) of 1   μ  M (  Fig. 4 B  ). 
Thus, direct physical interaction between AIF and CypA was 
demonstrated in vitro and in vivo after HI. 
  Double labeling of AIF and the DNA strand break marker 
Tdt-mediated dUTP-biotin nick-end labeling (TUNEL) re-
vealed intense nuclear AIF immunoreactivity in TUNEL-
positive cells from WT mice (  Fig. 5 A  ) but reduced nuclear 
AIF immunoreactivity in TUNEL-positive CypA      /      neu-
rons (  Fig. 5 B  ).   Similarly, TUNEL-positive nuclei in WT 
mice displayed strong CypA immunoreactivity (  Fig. 5 C  ), 
whereas AIF-defi  cient Hq mutant mice displayed weak CypA 
activation (  22  ), yet it stands in contrast with the notion that 
caspases, particularly caspase-3, are critically important for the 
development of brain injury in the immature brain (  22, 25  ). 
This may suggest that caspase-independent apoptosis-related 
cell-death mechanisms are particularly important in deter-
mining cell fate after brain injury. Clearly, the CypA  –  AIF 
interaction plays a greater role in pathological neuronal death 
than in normal, developmentally regulated programmed cell 
death, because CypA      /      mice do not display any dysmorphic 
or teratogenic features (  5  ). 
  Functional and physical interaction of CypA and AIF 
after HI in neurons 
  In healthy neurons, CypA is localized both in the cytoplasm 
and nuclei, whereas AIF is confi  ned to mitochondria. In 
WT mice, nuclear translocation of both AIF and CypA was 
evident in injured (pyknotic) neurons after HI, as judged by 
immunofl  uorescence stainings (  Fig. 3 A  ).   In a separate ex-
periment, 93% of the cells with nuclear AIF were identifi  ed 
as neurons (NeuN positive; unpublished data). In CypA      /      
mice, nuclear translocation of AIF could be detected in 
injured neurons, but the signal was very weak (  Fig. 3 B  ) com-
pared with WT mice (  Fig. 3 A  ). Conversely, in AIF-defi  cient 
  Figure 1.     Neuroprotective effects of CypA defi  ciency in a model of neonatal HI. (A) Representative MAP2 stainings obtained 72 h after HI at the 
dorsal hippocampus (left) and striatum (right) levels are shown for WT, CypA  /     , and CypA     /     brains. Brain injury was evident in the cortex, striatum, 
hippocampus, and thalamus, and was more pronounced in WT than in CypA     /     mice. (B) Neuropathological scores in the cortex (Ctx), hippocampus (Hip), 
striatum (Str), and thalamus (Tha). (C) The total infarct volume was reduced by 46.7% in CypA     /     ( n    19; P  0.0089) as compared with WT mice (  n    25) 
and by 38.3% as compared with CypA  /      mice  ( n    27; NS). (D) The volume of total tissue loss was measured 72 h after HI, as described in Materials 
and methods. The CypA     /     mice displayed 33.8% less tissue loss than the WT mice (P  0.0025) and 29.9% less than the CypA  /      mice  (P   0.0113). Data 
presented represent the mean      SEM. *, P      0.05; **, P      0.01; ***, P      0.001.   1744 NUCLEAR CO-TRANSLOCATION OF C  YP  A AND AIF | Zhu et al.
AIF and CypA reside in separate cellular compartments, with 
AIF in the mitochondrial intermembrane space and CypA 
in the cytoplasm and nuclei. Thus, both proteins would be 
prevented from interacting under normal conditions but can 
bind to each other upon induction of cell-death signaling and 
mitochondrial membrane permeabilization. The domain of 
the AIF protein that interacts with CypA is separate from its 
HSP70 interaction domain and from its DNA binding sites (  14  ). 
The domain of CypA that binds to AIF is separate from its 
catalytic domain and its binding site for CsA (  14  ). Previous 
studies could not conclusively determine in which sub-
cellular compartment the AIF  –  CypA interaction occurred, but 
it was assumed that AIF underwent electrostatic interaction 
with DNA (  26  ) and then tethered CypA to chromatin (  14  ). 
Our data suggest that the CypA  –  AIF interaction occurs be-
fore or when nuclear translocation begins, in the cytosol. 
immunoreactivity in TUNEL-positive nuclei (  Fig. 5 D  ). The 
number of TUNEL-positive nuclei also positive for AIF or 
CypA was determined in WT, CypA      /     , and Hq mice 24 h 
after HI within the penumbra. Approximately 253 TUNEL-
positive neurons per mm  2   displayed nuclear AIF staining in 
WT mice, whereas in CypA      /      mice the number of TUNEL-
positive cells with nuclear AIF staining was reduced by 90.7% 
(P      0.0001;   Fig. 5 E  ). Similarly, the number of TUNEL/
CypA double-positive neurons decreased by 79.4% in Hq com-
pared with WT mice (P      0.0004;   Fig. 5 F  ). Furthermore, the 
total number of TUNEL-positive cells after HI was reduced to 
a greater extent in CypA      /      and Hq mice than would be 
expected from the degree of protection (  Fig. 5, E and F  ). 
  These fi  ndings provide a possible mechanism whereby 
AIF could exert its proapoptotic eff  ects when released from 
mitochondria. We anticipate that under normal conditions, 
  Figure 2.     Apoptosis- and oxidative stress  –  related proteins under physiological and pathological conditions in WT and CypA      /      mice. 
(A) Immunoblots of CypA and selected apoptosis-related (AIF, cyt c, and Smac) and oxidative stress  –  related (SOD2 and Trx2) proteins in homogenates from 
nonischemic WT, CypA  /     , and CypA     /     brains  ( n    5 per group). CypA was not detectable in CypA     /     brains and was decreased     50% in CypA  /      mice. 
There were no detectable differences in AIF, Cyt c, Smac, SOD2, or Trx2 (P  0.43). Actin was used as a loading control. (B) Immunoblots of mitochondrial 
proteins in the ipsilateral (IL; ischemic, injured) and contralateral (CL; hypoxic, uninjured) cortex of WT and CypA     /     mice 24 h after HI. AIF, Cyt c, Smac, 
and SOD2 were decreased in the ipsilateral hemisphere, but the decrease was not different between WT and CypA     /     mice  (P   0.31). (C) Immunoblots of 
homogenates from the ipsilateral and contralateral cortex of WT and CypA     /     mice 24 h after HI. There were no differences in the levels of HSP70, cata-
lase, or SOD1, neither after HI nor between genotypes (P  0.25). The 240-kD cytoskeletal protein fodrin was cleaved into 145/150-kD calpain-related 
fragments and a 120-kD caspase-3  –  related fragment in the ipsilateral hemisphere, but the extent of cleavage was not signifi   cantly    difference  between 
WT and CypA     /     mice  (P   0.49). Calpain-induced cleavage of NCX1 was not different between genotypes (P  0.42). The white line indicates that inter-
vening lanes have been spliced out. (D) Caspase-3  –  like activity (DEVD cleavage) in the cortex from WT and CypA     /     mice in nonischemic control tissue 
(Cont) (P  0.12) and ischemic tissue 24 h after HI (P = 0.75) was not signifi  cantly different between WT and CypA     /     mice, despite the difference in 
infarct volume     (  n    6 per group). Data represent the mean  SEM.     JEM VOL. 204, August 6, 2007  1745
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This suggests a direct physical interaction between AIF and 
CypA, and this was confi  rmed using coimmunoprecipitation 
and surface plasmon resonance technology. Presumably, the 
physical interaction between CypA and AIF facilitates nuclear 
translocation of the two proteins as a complex. 
  In summary, this is the fi  rst study to our knowledge dem-
onstrating that elimination of CypA aff  ords  neuroprotec-
tion in vivo. It has been demonstrated in vitro that AIF and 
CypA cooperate in caspase-independent apoptosis-related 
DNA fragmentation. Our in vivo data support and extend 
this cooperative mechanism. Until now, the only possibil-
ity to inhibit the lethal action of AIF in HI was to prevent 
mitochondrial membrane permeabilization, e.g., by targeting 
the antiapoptotic Bcl-2 family protein Bcl-XL to neurons 
(  20  ), or to prevent the translocation of AIF to the nucleus by 
overexpressing transgenic HSP70 in neurons (  18  ). Our data 
demonstrate yet another possible strategy for inhibiting the 
action of AIF, namely by generating pharmacological inhibi-
tors of the CypA  –  AIF interaction. This strategy constitutes a 
challenging endeavor for future research. 
This is based on the observations that nuclear translocation of 
AIF was reduced (by     90%) in injured neurons in CypA      /      
mice and, conversely, that CypA translocation to nuclei was 
reduced (by     80%) in AIF-defi  cient Hq mice. Conclusively, 
these data suggest that CypA is required for effi   cient nuclear 
translocation of AIF in damaged neurons and, conversely, that 
AIF is needed for the nuclear translocation of CypA after HI. 
  Figure 3.     Nuclear translocation of AIF was impaired in the ab-
sence of CypA and vice versa. (A) Immunofl  uorescent labeling of AIF 
(red), CypA (green), and chromatin (HOECHST 33342; blue) 3 h after HI in 
WT type mice showing both strong AIF and CypA nuclear staining in an 
injured neuron, as judged by the condensed nuclear morphology. (B) La-
beling, as in A, in CypA     /     mice showing very weak nuclear AIF staining 
in injured neurons. (C) Labeling, as in A, in AIF-defi  cient Hq mice showing 
very weak CypA staining in injured neurons compared with WT type mice. 
Bar, 10    m.   
  Figure 4.     Physical interaction between CypA and AIF after HI in 
vivo and in vitro. (A) Coimmunoprecipitation of CypA and AIF in ische-
mic but not in nonischemic brain tissue. Immunoprecipitation of AIF in 
nonischemic control and ipsilateral, HI cortex homogenates 3 h after HI. 
(B) Surface plasmon resonance measurement of the CypA  –  AIF interaction. 
The curve demonstrates the net resonance signal in RU obtained by sub-
tracting the reference channel from the experimental channel. Recombi-
nant AIF protein was captured by an immobilized antibody raised against 
AIF, resulting in a 320-RU rise. Subsequent injection of CypA resulted in a 
123-RU rise, indicating CypA binding to AIF. This binding was reversible, 
because CypA dissociated upon change to buffer fl  ow until the initial 
plateau value was reached. The dissociation constant was calculated to 
   1     M. Repeated injections of CypA resulted in the same association and 
dissociation phases as found in the fi  rst injection.     1746 NUCLEAR CO-TRANSLOCATION OF C  YP  A AND AIF | Zhu et al.
  Figure 5.     Obligate cotranslocation of AIF and CypA into the nuclei of damaged neurons. DNA strand breaks in the cortex 3 or 24 h after HI were 
identifi  ed using TUNEL labeling (green) and correlated with AIF (A and B, red) or CypA (C and D, red) immunolabeling. Nuclear morphology was evaluated 
with HOECHST 33342 (blue). (A) A TUNEL-positive neuron (arrow, green) displaying strong nuclear AIF staining (red) and condensed chromatin (blue), 
unlike the noninjured, TUNEL-negative neurons. (B) In CypA     /     mice nuclear AIF staining (arrow, red) was weak in the TUNEL-positive neurons (green) 
with condensed chromatin (blue). (C) A TUNEL-positive neuron (arrow, green) displaying strong nuclear CypA staining (red) and condensed chromatin 
(blue), unlike the noninjured, TUNEL-negative neurons. Bar, 10     m. (D) In AIF-defi  cient Hq mice, TUNEL-positive neurons (arrow, green) with condensed 
nuclear morphology (blue) displayed weak nuclear CypA staining (red). (E) Quantifi  cation of TUNEL-positive cells with AIF-positive nuclei in the cortical 
penumbra 24 h after HI. WT brains contained 276      44 TUNEL-positive neurons per mm  2   24 h after HI, whereas CypA     /     mice displayed only 78      10 
neurons per mm  2   (**,  P   0.0003). The density of cells positive for both TUNEL and AIF was 253      40 cells per mm  2   in WT and 23      6 cells per mm  2   in 
CypA     /     mice (  n    6 per group; ***, P      0.0001). (F) Quantifi  cation of TUNEL-positive cells with CypA-positive nuclei in the cortical penumbra 24 h after 
HI. WT mice exhibited 170      31 TUNEL-positive neurons per mm  2   24 h after HI, whereas this value amounted to 64      8 neurons per mm  2   in Hq mice 
(**, P  0.0011). The density of cells positive for both TUNEL and CypA was 150      28 cells per mm  2   in WT and 29      2 cells per mm  2   in Hq mice (  n    6 per 
group; ***, P      0.0004).   JEM VOL. 204, August 6, 2007  1747
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gels (Novex) and transferred to reinforced nitrocellulose membranes 
(Schleicher   &   Schuell). The following primary antibodies were used: anti-
actin (1:200; Sigma-Aldrich), 0.2     g/ml anti-AIF, 1     g/ml anticatalase 
(clone 11A1; Lab Frontier), anti-CypA (1:4,000), anti  –  cytochrome c (1:500; 
clone 7H8.2C12; BD Biosciences), 0.2     g/ml antifodrin (clone AA6; BIO-
MOL Research Laboratories, Inc.), 0.5     g/ml anti  –  heat-shock protein 70 
(HSP 70; Santa Cruz Biotechnology, Inc.), 0.7     g/ml anti-Smac (Santa 
Cruz Biotechnology, Inc.), 0.5     g/ml anti  –  superoxide dismutase I (Cu/
Zn-SOD/SOD1; Lab Frontier), 0.5     g/ml anti  –  superoxide dismutase II 
(Mn-SOD/SOD2; clone 2A1; Lab Frontier), 1     g/ml anti  –  thioredoxin 2 
(Trx2; Lab Frontier), and 0.25     g/ml anti-NCX1 (1:800; Santa Cruz Bio-
technology, Inc.). Peroxidase-labeled secondary antibodies (1:2,000 goat 
anti  –  rabbit, 1:2,000 horse anti  –  goat, or 1:4,000 horse anti  –  mouse) were 
obtained from Vector Laboratories. Immunoreactive species were visualized 
using a substrate (Super Signal Western Dura; Pierce Chemical Co.) and a 
cooled CCD camera (LAS 3000; Fuji). 
  Caspase activity assays.     25-    l homogenate samples were mixed with 
75     l of extraction buff  er, as previously described (  28  ). Cleavage of Ac-DEVD-
AMC (for caspase-3; Peptide Institute) was measured with an excitation 
wavelength of 380 nm and an emission wavelength of 460 nm and expressed 
as picomoles of AMC released per milligran of protein per minute. Cleavage 
of Ac-LEHD-AFC (for caspase-9; Enzyme System Products) was measured 
as for the AFC conjugates, but with an excitation wavelength of 400 nm and 
an emission wavelength of 505 nm, and expressed as picomoles of AMC re-
leased per milligran of protein per minute. 
  Injury evaluation.     Brain injury was evaluated by neuropathological scoring 
as well as calculating infarct volume and the volume of total tissue loss at 
72 h after HI (  22  ). Sections were stained for MAP2 and scored by an observer 
blinded to the genotype of the mice. The total score (0  –  22) was the sum of 
the scores for all four regions (cortex, hippocampus, striatum, and thalamus) 
(  29  ). The infarct areas (MAP2 negative) were measured using Micro-Imaging 
(Olympus). Total tissue loss was calculated as the MAP2-positive areas in the 
contralateral hemisphere minus the MAP2-positive areas in the ipsilateral 
hemisphere (  29  ). 
  Immunoprecipitation.     AIF was immunoprecipitated from control tissue 
or ipsilateral (ischemic) hemispheres 3 h after HI. Homogenate samples con-
taining equal amounts of protein were precleaned with goat IgG and 
PANSORBIN cells (Calbiochem), followed by the addition of 1     g anti-
AIF (sc-9416; Santa Cruz Biotechnology, Inc.) and incubation overnight at 
4  °  C. Immune complexes were sequestered through the addition of 50     l of 
Pansorbin cells and incubation for an additional 2 h at 20  °  C. The resulting 
immobilized immune complexes were pelleted by centrifugation at 3,000   g   
for 5 min at 4  °  C and washed four times with 0.5 ml homogenizing buff  er. 
The bound proteins were eluted by heating in NuPAGE LDS 4  	   sample 
buff  er for 10 min. Immunoprecipitated proteins were subjected to immuno-
blotting and examined for AIF and CypA immunoreactivity. 
  Surface plasmon resonance.     CypA interaction with AIF was explored 
with the surface plasmon resonance technique, using a BIACORE 3000 
(Biacore AB). The Biacore HBS-EP buff  er (10 mM Hepes, 150 mM NaCl, 
3.4 mM EDTA, and 0.01% polysorbate P20, pH 7.4) was used as a run-
ning buff  er at 5     l/min and 25  °  C in all experiments. A goat polyclonal 
anti-AIF (0.05     g/ml in 10 mM sodium acetate, pH 5) was amine-coupled 
to a CM4 sensor chip (Biacore AB), according to the standard procedure 
recommended, to a response of 6,000 resonance units (RU). 100     l, 0.2     g/ml 
AIF protein (  30  ) in running buff  er with 1 mM nicotinamide adenine di-
nucleotide phosphate (NADPH) was passed over the surface, resulting in 
binding of 320 RU (  Fig. 4  ). Captured AIF was apparently tightly bound 
to the antibody surface, because the dissociation rate was very slow. 75     l, 
25 nM CypA protein (Affi   nity BioReagents, Inc.) in running buff  er with 
1 mM NADPH was injected. After association of CypA to 123 RU, CypA 
dissociated upon change to buff  er fl  ow until the initial plateau value for the 
  MATERIALS AND METHODS 
  HI.     CypA      /      mice (  5  ) and their heterozygous (CypA  /     ) or WT littermates 
of either sex were subjected to unilateral HI on postnatal day 9 (P9), essen-
tially according to the Rice-Vannucci model (  25  ). AIF-defi  cient Hq male 
mice (  24  ) and their WT littermates were subjected to the same procedure. 
In brief, mice were anesthetized with isofl  urane, and the left common ca-
rotid artery was cut between double ligatures of prolene sutures. After sur-
gery, the pups were allowed to recover for 1  –  1.5 h with the dam and were 
then placed in a chamber perfused with a humidifi  ed gas mixture (10% oxy-
gen in nitrogen) for 45 min. After hypoxic exposure, the pups were returned 
to their biological dams until they were killed. Interesting diff  erences be-
tween neuronal mechanisms of injury in neonatal male and female brains 
have been observed, including more pronounced nuclear translocation of 
AIF during early reperfusion (P < 0.05) (  27  ). We did not fi  nd any signifi  cant 
diff  erences between males and females regarding the injury observed or the 
frequency of neurons with nuclear AIF (unpublished data), as expected at the 
particular time points of evaluation shown in the fi  gures (  22, 27  ), so both 
male and female CypA      /     , CypA  /     , and WT pups were included in this 
study. All animal experimental protocols were approved by the G  ö  teborg 
committee of the Swedish Animal Welfare Agency (application nos. 94  –
  2003 and 184  –  2003). 
  Genotyping.     Hq genotyping was previously described (  22  ). For CypA 
mice genotyping, the following primers were used: CypA common, 
5  
  -GCAGTTGTGATTGATCCAGGTCCG-3  
  ; CypA WT, 5 
  -CACCCT-
GGAGCACCACTGCCCACC-3  
  ; and CypA mutant, 5 
  -CCTGATCGA-
CAAGACCGGCTTCC-3  
  . CypA      /      mice were identifi  ed by the presence 
of a single 520-bp DNA band. WT mice were identifi  ed by a single 200-bp 
product. CypA  /      mice were identifi  ed by the presence of both bands. 
  Immunohistochemistry.     Mice were deeply anesthetized with 50 mg/ml 
phenobarbital and perfusion fi  xed with 5% formaldehyde. Brains were de-
hydrated with xylene and graded ethanol, paraffi   n embedded, and serial cut 
into 5-    m coronal sections. Sections were deparaffi   nized, and antigen re-
trieval was performed by boiling them in 10 mM sodium citrate buff  er (pH 6) 
for 10 min. Nonspecifi  c binding was blocked for 30 min with 4% horse 
serum in PBS. 4     g/ml anti  –  microtubule-associated protein 2 (anti-MAP2; 
clone HM-2; Sigma-Aldrich) was incubated for 60 min at 20  °  C, followed by 
another 60 min with 2     g/ml of a biotinylated horse anti  –  mouse IgG di-
luted in PBS. Visualization was performed using Vectastain ABC Elite (Vec-
tor Laboratories). 
  Immunofl  uorescence staining.     Antigen retrieval was performed as de-
scribed in the previous section. Nonspecifi  c binding was blocked for 30 min 
with 4% donkey serum in PBS. 2     g/ml anti-AIF (goat polyclonal antibody; 
Santa Cruz Biotechnology, Inc.) and anti-CypA (1:400; rabbit polyclonal 
antibody; BIOMOL Research Laboratories, Inc.) or anti-NeuN (1:500; 
clone HM-2; Sigma-Aldrich) in PBS were incubated overnight at 4  °  C. After 
washing with PBS, sections were incubated with donkey anti  –  goat 546 
(1:150) and donkey anti  –  rabbit 488 (1:150) or donkey anti  –  mouse 488 
(1:150) in PBS for 2 h at room temperature, and were subsequently placed 
in HOECHST 33342 (Invitrogen) at 1     g/ml in PBS for 10 min at 20  °  C 
with gentle agitation, washed, and mounted using Vectashield mounting 
medium. For TUNEL and AIF or CypA double labeling, sections were 
incubated with 3% bovine serum albumin in 0.1 M Tris-HCl (pH 7.5) for 
30 min, followed by 50     l of TUNEL reaction mixture (Roche) on each 
sample for 60 min at 37  °  C in a moist chamber. After washing, the sections 
were blocked with 4% donkey serum and incubated either with anti-AIF or 
anti-CypA, as described. Secondary donkey anti  –  goat 546 (for AIF) or don-
key anti  –  rabbit 546 (for CypA; Invitrogen) was used, and staining with 
HOECHST 33342 was performed as described. 
  Western blot analysis.     Homogenates and cellular fractions from parietal 
cortex (harboring both injured and intact tissue) were prepared as previ-
ously described (  22  ). The samples were run on 4  –  12% NuPAGE Bis-Tris 1748 NUCLEAR CO-TRANSLOCATION OF C  YP  A AND AIF | Zhu et al.
bound AIF was reached. A dissociation equilibrium constant for AIF and 
CypA of     1     M was determined using BIAeval software (Biacore AB), 
assuming mass transport. 
  Statistics.     All data were expressed as mean      SEM. The Student  ’  s   t   test was 
used when comparing two groups, whereas analysis of variance with Fisher  ’  s 
post-hoc test was used when comparing three or more groups. The Mann-
Whitney U test was used when comparing the ratios of double-positive cells. 
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